Cited by 10Endometrial and Cervical Cancer TreatmentsOvarian cancer diagnosis and treatmentEndometriosis Research and Treatment

Incisional carcinoma of Mullerian Origin: A case report and review of literature

Open access
Bedell, Sabrina, Chang, Zenas, Burt, Cassaundra, Khalifa, Mahmoud A., Argenta, Peter A.·2020·Gynecologic Oncology Reports

Abstract

Primary incisional carcinoma (PIC) is a rare, delayed complication of surgery, usually attributed to the malignant transformation of endometriosis. We report a case of incisional carcinoma with nodal metastases in a 55-year-old woman, 18 years after cesarean section. She underwent extirpative surgery, including hysterectomy and bilateral salpingo-oophorectomy, without intraperitoneal disease identifed. Adjuvant treatment included sandwiched platinum-based chemotherapy (carboplatin and paclitaxel) and radiation. She remains disease-free 8 months after completing therapy. We identified 46 additional reported cases. Of these, >90% had undergone an "endometrium-exposing" surgery, most commonly cesarean section; while no cases followed adnexal-only surgery. The median time between antecedent surgery and presentation was 18 years. At presentation, tumors were often large (median 8 cm), and symptomatic with pain (63%) and/or mass (26%). Serum CA125 levels were commonly, albeit slightly, elevated (median 57U/ml (IQR 22-96, Range 6-1690)). Lymph node metastases were common (35%), with most following a vulvar-type spread pattern (inguinal first). Most patients (63%) were treated with chemotherapy +/- radiation. Approximately 50% of patients recurred promptly (median < 6 months), but long-term survival was reported following combined chemotherapy/radiation. Lymph node metastases portended a shorter disease-free interval, with 73% of cases recurring (median 5 months) despite chemotherapy-based treatment. These data suggest that some incisional carcinomas may result from displacement of healthy endometrium followed by delayed malignant transformation. Chemotherapy-only and radiation-only treatments are attended by modest prognosis. Taken together, these data suggest there is both need and potential avenues for improved prevention, detection, and treatment of this condition.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.gore.2020.100588

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • 90% of malignant scar endometriosis have undergone previous gynecological procedures with endometrium exposure, including cesarean sections.

    “It must be emphasized that 90% of malignant scar endometriosis have undergone previous gynecological procedures with endometrium exposure, including and not limited to cesarean sections, therefore making the translocation theory more plausible [31].”

    From Malignancy in Abdominal Wall Endometriosis: Is There a Way to Avoid It? A Systematic Review (2024) · cites this paper as [31]

    The Discussion > Origin (page unavailable) reports that over 90% of patients with primary incisional carcinoma had undergone procedures with possible endometrial exposure, including cesarean section, and presents this as support for translocation. The claim narrows that group to malignant scar endometriosis, but the paper says primary incisional carcinoma can occur without associated endometriosis. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • The translocation theory holds that benign endometriosis is iatrogenically transported to the surgical scar where it transforms into neoplasia.

    “The second theory is the “translocation theory”. According to this theory, benign endometriosis is iatrogenically transported to the surgical scar where it transforms into neoplasia.”

    From Malignancy in Abdominal Wall Endometriosis: Is There a Way to Avoid It? A Systematic Review (2024) · cites this paper as [31]

    The Discussion > Origin passage describes surgical translocation of benign endometrial gland cells followed by malignant transformation. It distinguishes that mechanism from malignant transformation of established endometriosis; the claim conflates them by saying benign endometriosis itself is transported. Page numbers are not provided in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • The translocation theory is more plausible than the primary incisional carcinoma theory.

    “It must be emphasized that 90% of malignant scar endometriosis have undergone previous gynecological procedures with endometrium exposure, including and not limited to cesarean sections, therefore making the translocation theory more plausible [31].”

    From Malignancy in Abdominal Wall Endometriosis: Is There a Way to Avoid It? A Systematic Review (2024) · cites this paper as [31]

    The Discussion > Origin reports that over 90% of patients with primary incisional carcinoma had undergone procedures with possible endometrial exposure and presents this as evidence for translocation. It does not establish that translocation is more plausible than another mechanism overall; it describes primary incisional carcinoma as the condition to be explained, not a competing theory. The cited figure also concerns patients with primary incisional carcinoma, rather than specifically malignant scar endometriosis. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Half of the 11 patients with lymphatic metastases and available follow-up, who received adjuvant chemotherapy, died of the disease within a median of 11.5 months.

    “Half of the 11 patients with lymphatic metastases and available follow-up, who received adjuvant chemotherapy, died of the disease within a median of 11.5 months [31].”

    From Malignancy in Abdominal Wall Endometriosis: Is There a Way to Avoid It? A Systematic Review (2024) · cites this paper as [31]

    The Discussion’s “Adjuvant treatment and prognosis” section reports follow-up for 11 patients with lymph-node metastases, all referred for adjuvant chemotherapy. Four of the eight who recurred—not half of all 11—died of disease at a median of 11.5 months. (LLM, conf=0.93)

    Experimental — accuracy not yet measured
  • This long interval is in favor of the translocation theory of benign endometriosis.

    “This long interval is in favor of the translocation theory of benign endometriosis [31].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 52 · Cited by 10

Authors
Bedell, S., Chang, Z., Burt, C., Khalifa, M. A., & Argenta, P. A.
Affiliations
University of Minnesota (US)
Corresponding author
Argenta, Peter A.
Venue
Gynecologic Oncology Reports
Publisher
Elsevier BV
Published
2020-08
Volume
33
Pages
100588
ISSN
2352-5789 (ISSN-L)
OpenAlex
W3026548657
Cited by
10
References
52
Citations by year
2025: 1 · 2024: 2 · 2022: 2 · 2021: 4 · 2020: 1
FWCI
1.07
Type
journal article
Language
en
Open access
Locations
  • Gynecologic Oncology Reports (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian cancer diagnosis and treatment
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
Keywords
endometriosis-associated cancer, cesarean section, hysterectomy, bilateral salpingo-oophorectomy, lymph node metastasis, carboplatin, paclitaxel, adjuvant chemotherapy, radiotherapy, CA125, recurrence, long-term survival

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review